SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(6 sites)
United States
Emory University, Atlanta, Georgia IU Health Joe and Shelly Schwarz Cancer Center, Carmel, Indiana Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana Roswell Park Comprehensive Cancer Center, Buffalo, New York Duke University, Durham, North Carolina Last updated January 2026